updates in nutrition and exercise
play

Updates in Nutrition and Exercise: New Trials and New Guidelines - PowerPoint PPT Presentation

Updates in Nutrition and Exercise: New Trials and New Guidelines for the Average Adult Jeffrey A. Tice, MD Professor of Medicine I HAVE NO CONFLICTS OF INTEREST Division of General Internal Medicine University of California, San Francisco In


  1. Updates in Nutrition and Exercise: New Trials and New Guidelines for the Average Adult Jeffrey A. Tice, MD Professor of Medicine I HAVE NO CONFLICTS OF INTEREST Division of General Internal Medicine University of California, San Francisco In the news last month… • Annals of Internal Medicine – Conclusion: Use of dietary supplements is not associated with mortality benefits among U.S. adults • Canadian Medical Association Journal – Use of vitamin D drops leading to kidney failure in a 54-year-old man Page 1

  2. Audience Question #1 Vitamins / supplements to be covered • Antioxidants briefly Are you currently taking: • Folate / Homocysteine briefly 41% 41% A. Vitamins? • Vitamin D / Calcium B. Other supplements? – USPSTF, New trial C. Both? 19% • Fish oil / Omega-3 D. Neither – CVD, Diabetes, New Trial 0% ? ? ? r • 2018 Exercise Guidelines s s h e n t t h m i n o t e B i m e a N t V i e p l p u s r e h t O Vitamin Use in the U.S.A. “To improve or maintain overall health.” Why antioxidants? • Antioxidants prevent the free radical damage • 52% of Americans and increasing that is associated with cancer, heart disease, – More than doubled since 1970s and aging • $41 billion on supplements in 2016 • Antioxidants are provided by a healthy diet that includes a variety of fruits and • Reports from observational studies of diet vegetables are very popular with patients and are • Observational studies consistently show always in the news higher intake / blood levels associated with • MVI, Vitamins C & D, calcium, omega-3s less cancer, heart disease, and death Dickinson, JACN, 2014 Page 2

  3. ß Carotene and Retinol Efficacy Trial (CARET) CARET Randomized Trial Results • Subjects > 18,000 participants followed for 4+ years on beta-carotene or placebo –18,000 smokers –Ages 45 – 74 • RCT ß-carotene 30 mg • Outcome: Lung CA, Death, CVD death Omenn, NEJM, 1996 Vitamin E The answer! • The primary fat soluble anti-oxidants • Meta-analysis of 47 high quality • US RDA 22 IU in men and women randomized trials of antioxidants • Deficiency: Rare • 181,000 individuals • Observational studies: dose response • 25,000 deaths reduction in CVD events up to daily intake > 200 IU per day Bjelakovic, JAMA, 2007. Page 3

  4. Death from any cause • Vitamin A 16% increase Folate, Homocysteine, and Heart • Beta-carotene 7% increase Disease • Vitamin E 4% increase • Vitamin C Trend towards increase (6%) All p << 0.05 except vitamin C Bottom line: actively discourage anti-oxidant use Bjelakovic, JAMA, 2007. Homocysteine and Risk of Death The Answer! Homocysteine RR • Pooled meta-analysis of 8 large, high < 9 1.0 quality randomized trials 9-14.9 3.3 • 37,485 individuals 15-19.9 6.3 ≥ 20 9.9 p<0.001 • 5,125 deaths • 9,326 major vascular events Observational study! • 3,010 cancers Nygard, NEJM, 1997 Clarke, Archives IM, 2010. Page 4

  5. Folate / Homocysteine RCTs Folate And Neural Tube Defects (NTD) • 70% reduction in 2 nd occurrences • Homocysteine 25% decrease – 4 mg of folate • Death No effect: 1.02 (.97-1.08) • 63% reduction in 1 st occurrence • CVD events No effect: 1.01 (.97-1.05) – 0.4 mg of folate • Since flour fortification • Cancer No effect: 1.05 (.98-1.13) Meta-analysis, Blencowe, IJE, 2010. – 46% reduction in NTD Folate does not prevent cancer or heart disease Clarke, Archives IM, 2010. Audience Question #2 The 2018 US Preventive Services Task Force updates recommend Vitamin D for: 48% A. Prevention of falls B. Prevention of fractures 27% C. Both That is the question! 15% TO D OR NOT TO D...? 9% D. Neither h r s s e l l e t a r o h B t f u i f t e o c N a n r o f i f t o n e n v o e i r t P n e v e r P Page 5

  6. Vitamin D: Institute of Medicine Report Adult Dietary Reference Intake* (U.S.) • Age • 1-70 years 600 IU / day • > 70 years 800 IU / day Panel reviewed 1000 studies on 25 health outcomes to update *Institute of Medicine, 2010: Sufficient to meet the needs of virtually previous 1997 recommendations all people. Vitamin D levels in Americans Vitamin D: The New Panacea • Reduces the following diseases... Prevalence of inadequate 25(OH) vitamin D – Cancer (Colon, Breast, Prostate, Pancreatic, ...) among American women ≥14 years old by – Cardiovascular disease IOM definitions – Multiple sclerosis, Type 1 DM, RA < 12 ng/ml 10 to 12% At risk of deficiency – Influenza and URIs < 20 ng/ml 34 to 39% At risk of inadequacy < 30 ng/ml ~80% – Chronic pain – Total Mortality! Why so little D? NHANES 2003-2006 Page 6

  7. RCT: VIDARIS Trial, JAMA, October 2012 VITAL (VIT D and OmegA-3 TriaL) • RCT n = 25,871 • 322 healthy adults in New Zealand • Vitamin D3 2000 IU daily; adherence 80% • 100,000 IU D3 monthly • Follow-up: Median 5.3 years (3.8-6.1) • 18 months follow-up • Participants 25(OH) D URI incidence – 67.1 years old – 51% female Vitamin D 48 ng/mL 3.7 infections/person – 20% Black, 4% Hispanic, 71% NHW Placebo 25 ng/mL 3.7 infections/person Manson et al, NEJM, 2018 VITAL: Vitamin D Results US Preventive Services Task Force Outcome Hazard Ratio (95% CI) • 2018 Cancer* 0.96 (0.88-1.06) – Vitamin D for fracture prevention (I) Breast Cancer 1.02 (0.79-1.31) Death from Cancer 0.83 (0.67-1.02) – Vitamin D for fall prevention (D) Major CVD Event* 0.97 (0.85-1.12) Death from CVD 1.11 (0.88-1.40) I = Insufficient evidence: the balance of benefits and Myocardial Infarction 0.96 (0.78-1.19) harms cannot be determined D = The USPSTF recommends against the service. There Death from Any Cause 0.99 (0.87-1.12) is moderate or high certainty that the service has no net * Co-Primary Endpoints ; 24 endpoints reported in Table 2 benefit or that the harms outweigh the benefits. Manson et al, NEJM, 2018 Page 7

  8. IOM Report Calcium What About Calcium? Recommendations DRI – Adequate Intake Adolescents: 1300 mg/day Women and men (19-50 years): 1000 mg/day Women and men (>50 years): 1200 mg/day Current intake levels: Women: ~1/3 of their recommended intake Men: ~3/4 of their recommended intake 2500 mg/day Tolerable Upper Intake Level: Meta-analysis Annals IM 10/25/2016 Vitamin D and Calcium Take Home Points • Target frail, older patients • Calcium intake in RDA range is not • 800 IU of vitamin D3 per day is sufficient associated with CVD in health adults – Ensure adequate calcium intake – Dietary calcium preferred • Editorial • Evidence is strong: no benefit for other diseases – Imperfect evidence • Avoid large doses of either supplement – Diet is safer (fewer kidney stones) – Low fat dairy, tofu, canned fish with bones: 2-3 servings/day Page 8

  9. Omega-3 Fatty Acids • Oily, cold water fish = best sources of Ω- 3 fatty acids –EPA = eicosapentanoic acid –DHA = docosahexanoic acid • People who consume fish rich in EPA and DHA have fewer fatal and non fatal CV events • 1-2 servings/week fish associated with A fishy story… 36% less risk of CV death and 17% less OMEGA 3 FATTY ACIDS total mortality Randomized trials of Ω-3s in heart disease VITAL (VIT D and OmegA-3 TriaL) • RCT n = 25,871 • GISSI-Prevention: Lancet 1999 – Only positive trial • Murine omega-3 FA 1 g daily; adherence 80% • 2010: 5 studies. NEJM, Circ, JAMA, BMJ • Follow-up: Median 5.3 years (3.8-6.1) – Not even a trend towards benefit for post-MI, CVD or atrial • Participants fibrillation – 67.1 years old • Intubated with acute lung injury: JAMA 2011 – 51% female – Harm: 3 extra days in ICU, trend - more death (p=0.054) – 20% Black, 4% Hispanic, 71% NHW • 2018: RCT in >15,000 patients w/ diabetes, new MA – No benefit Manson et al, NEJM, 2018 Page 9

  10. VITAL: Omega-3 FA Results Summary Omega-3 FA / Fish oil Outcome Hazard Ratio (95% CI) • No benefit in modern era of medical Cancer* 1.03 (0.93-1.13) therapy for vascular disease Breast Cancer 0.90 (0.70-1.16) Death from Cancer 0.97 (0.79-1.20) • No significant harms: trend towards fewer deaths in most trials, though not Major CVD Event* 0.92 (0.80-1.06) Death from CVD 0.96 (0.76-1.21) VITAL Myocardial Infarction 0.72 (0.59-0.90) • Discourage use Death from Any Cause 1.02 (0.90-1.15) * Co-Primary Endpoints; 24 endpoints reported in Table 2 Manson et al, NEJM, 2018 General principles Summary • Beta-carotene Discourage - harmful • Eat enough to avoid deficiency • Vitamin E Discourage - harmful • Doses significantly above RDAs are • Folate For child-bearing age to unhelpful and may be harmful prevent neural tube defects • Vit D + calcium Older, frail patients to ≠ prevent fractures • Fish oil / Omega Discourage – no benefit 3 FA Page 10

  11. Michael Pollan ’ s Recommendations • Eat real food • Not too much • Mostly plants ? Move SO WHAT ELSE CAN WE DO? • Some fish • Mediterranean Diet Key Evidence Based Benefits (RCT) of Exercise • Improves sleep quality Physical Activity and Health • Improves cognitive function • Reduces depression and anxiety 2018 Physical Activity Guidelines • Improves quality of life Advisory Committee Scientific Report, • Prevent falls, fractures, obesity, 2 nd Edition diabetes, cancer, CAD, dementia … US Dept of Health and Human Services 2018 Physical Activity Guidelines Page 11

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend